Seeking Alpha

dpk

dpk
Send Message
View as an RSS Feed
View dpk's Comments BY TICKER:
Latest  |  Highest rated
  • Mannkind Reality Check Redux: 82.4 Million Reasons To Leave Your Lover! [View article]
    We all genuinely wish inhaler to succeed but do we really consider this is one of the best place to keep the money purely from Rules of investing point of view?
    If no,then let us simply admit,we are in love with the stock.
    Dec 10, 2014. 03:58 AM | Likes Like |Link to Comment
  • A Comprehensive Comparison Of Gilead's Harvoni And AbbVie's Triple HCV Regimen: What The HCV Marketplace May Look Like In 2015 And Beyond [View article]
    From curing point of view out of 2,gild convincing looks a winner but from a position point of view,ACHN may have a better risk reward for some.
    Whereas risk for Gild is minuscule but reward of Achn could be mind boggling thus compensate of risk part that too before even 2015 begins.
    Author a few lines in comments section on ACHN may make it more spicy.It may be a wiser pharmaset in making.
    Dec 8, 2014. 03:49 PM | 1 Like Like |Link to Comment
  • 8 Major Reasons Why The Current Low Oil Price Is Not Here To Stay [View article]
    http://cnb.cx/ZWvWcz
    A must see.
    Dec 4, 2014. 12:42 AM | 1 Like Like |Link to Comment
  • MannKind: Strategy, Accounting, And Technosphere At Piper Jaffray Healthcare Conference [View article]
    Thanks author for your time.it is fun to be in coterie of geniuses.
    Dec 3, 2014. 02:49 PM | 2 Likes Like |Link to Comment
  • MannKind: Strategy, Accounting, And Technosphere At Piper Jaffray Healthcare Conference [View article]
    " Asked how MNKD can be sure they won't be charged for the expenses of Sanofi sales reps making visits in which they promote their other drugs, rather than Afrezza, the MannKind representative replied that the costs of marketing are apportioned according to the success of the products being marketed. So if Afrezza isn't getting pushed, and isn't selling, MNKD won't be paying for those calls."

    Fingers crossed but thinking of a particular situation.Assume Afrezza is most successful,marketing exps of Sanofi products will be charged to Afreeza even for those visits where afrezza gets little mention or no mention.
    " Not only must Justice be done; it must also be seen to be done."
    Dec 3, 2014. 01:33 PM | 3 Likes Like |Link to Comment
  • Swatch CEO says he's unfazed by Apple Watch [View news story]
    Girls/Nick hold your heart/sales,Byron/Apple is coming.
    Who knows as 'Google'replaced term 'search',iwatch may replace watch.And Apple may also add to manufacture designed watches in times to come.
    Nov 27, 2014. 10:33 PM | Likes Like |Link to Comment
  • Puma Is As Expensive As MannKind Is Cheap [View article]
    And in supplement to that online news like briefing.com also.
    Nov 25, 2014. 08:30 PM | Likes Like |Link to Comment
  • Puma Is As Expensive As MannKind Is Cheap [View article]
    SA should think of starting 24/7 stocks channel.Yahoo is free to buy advs there.
    That way competition will keep not honest views away.
    Nov 25, 2014. 08:04 PM | Likes Like |Link to Comment
  • Puma Is As Expensive As MannKind Is Cheap [View article]
    Thanks for the detailed article which simplified what is this mysterious PBYI, George, which really baffled all that how this stock jumped by absurd 295% without any apparent solid footing.
    Just to reiterate what I understood about PBYI:
    1. Still to file NDA with FDA for their ONLY product PB272
    2. Shortening the trial period from Five to Two years
    3. Reduced the number of participants in trials by roughly 1000
    4. Third-party payers agreeing to cover an expensive drug that's proven relatively effective only during a period when patients are already largely healthy.
    5.Rely on third party contractors for pre-clinical and clinical testing, and also to manufacture, supply, store, and distribute supplies necessary for even ongoing clinical trials.
    6. An analyst citing an anonymous hedge fund manager who's very bullish on the stock and used five-to-one price-to-sales ratio for the year 2021.
    7. Pfizer amending the original agreement and got away with 30 million by reducing some percentage of royalty.
    Please let me know if I misunderstood or missed anything!
    And thx again also for reemphasizing the belief for MNKD Afrezza
    reg
    dpk
    Nov 25, 2014. 01:22 AM | 5 Likes Like |Link to Comment
  • MannKind: Does Size Matter? [View article]
    I got zpoet comment requested for deletion.It must be a slip in language in love for the stock.
    Nov 25, 2014. 12:25 AM | Likes Like |Link to Comment
  • Sanofi's New Medicines Seminar: Implications For Afrezza [View article]
    Thanks Robert.
    Nov 22, 2014. 02:13 AM | 3 Likes Like |Link to Comment
  • Sanofi's New Medicines Seminar: Implications For Afrezza [View article]
    The main subject matter of the article as I understood was,'if at seminar afreeza got the proper exposure'.
    My comment was only with respect to that and primary facie, it was step mothely treatment.
    As I am aggressively long too with jan 2016 spreads so by mentioning sanofi faux paus side by side,I was trying to further explore author's various corners of brain.'What else',a term used by Jack Schwager,while interviewing market wizards.
    Nov 21, 2014. 06:11 PM | 2 Likes Like |Link to Comment
  • Sanofi's New Medicines Seminar: Implications For Afrezza [View article]
    Shorts may not be wrong as Sanofi at Seminar either did not follow the rule to put best foot forward or followed the rule and did not consider Afrezza as best foot.
    Sometimes it makes me wonder how love for a stock can make best of an analyst ( here PA of Sanofi fame) not to see what was so obvious.
    ( A guest comes to your home and he is made to attend by maid only and you rationalize later he was not a guest but a family member)
    But I wish I am wrong as I am too in love with the inhaler,CEO and PA.
    Nov 20, 2014. 11:56 PM | 3 Likes Like |Link to Comment
  • Why We're Huge Fans Of Gilead [View article]
    How come insiders know less than bulls?
    Gild has given us lot of money,may be because of that we are having less fear of potential dangers.
    Nov 20, 2014. 01:18 AM | 1 Like Like |Link to Comment
  • Khan Resources: A Special Situations Case For November And December [View article]
    Bill Gates said,there is injustice in the world.Khan proposes corruption disposes.
    A well researched idea.But author could not see any trading in this symbol.How to take a position?.
    Nov 19, 2014. 02:14 PM | Likes Like |Link to Comment
COMMENTS STATS
411 Comments
407 Likes